title: Retraction for Lammerts van Bueren et al. The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.
authors.forename: Jeroen J
authors.initials: JJ
authors.lastname: Lammerts van Bueren
authors.forename: Wim K
authors.initials: WK
authors.lastname: Bleeker
authors.forename: Annika
authors.initials: A
authors.lastname: Brännström
authors.forename: Magnus
authors.initials: M
authors.lastname: Jansson
authors.forename: Matthias
authors.initials: M
authors.lastname: Peipp
authors.forename: Tanja
authors.initials: T
authors.lastname: Schneider-Merck
authors.forename: Thomas
authors.initials: T
authors.lastname: Valerius
authors.forename: Jan G J
authors.initials: JG
authors.lastname: van de Winkel
authors.forename: Paul W H I
authors.initials: PW
authors.lastname: Parren